about
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Enga...
Read More
1.76
-0.03
(-1.68%)
2,976
XNAS Volume
XNAS 26 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Innate Pharma (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..